Free Trial

Exela Technologies (XELA) Stock Price, News & Analysis

+0.03 (+1.30%)
(As of 11:48 AM ET)
Today's Range
50-Day Range
52-Week Range
9,969 shs
Average Volume
139,281 shs
Market Capitalization
$14.91 million
P/E Ratio
Dividend Yield
Price Target
XELA stock logo

About Exela Technologies Stock (NASDAQ:XELA)

Exela Technologies Inc is a global leader in business process automation and information management solutions. The company is headquartered in Irving, Texas, was founded in 2017 and operates in over 50 countries. Exela helps its clients to streamline their business operations, reduce costs and improve customer engagement through its proprietary platform and suite of solutions.

The company's services include document management, payment processing, human resources management and customer care. Exela's clients come from diverse industries, including healthcare, finance, insurance and government.

Exela has been recognized for its excellence in information management, having won numerous awards for its innovative solutions. The company was named a "Leader" in the Gartner Magic Quadrant for Intelligent Business Process Management Suites in 2020.

Exela's leadership team comprises experienced professionals with a wealth of knowledge in business process automation and information management knowledge. Ron Cogburn serves as the company's CEO and Chairman of the Board. Cogburn has over 30 years of experience in the technology industry and has held leadership positions at several successful companies. He is committed to driving innovation and growth at Exela.

Exela Technologies Inc has seen steady revenue over the past few years, with revenues ranging between $250 million and $300 million. Exela's profit margins have remained relatively stable over the past few years, with average gross margins of 35.5% and a net margin averaging around -10%. The company's debt levels have decreased slightly over the past several years, insinuating an effort to pay down liabilities. However, it is essential to note that Exela Technologies' price-to-earnings ratio and price-to-book ratios are significantly lower than the industry averages. Exela's stock price has experienced significant volatility over the past few years. The company's trading volume has also been extremely high, with an average of 190 million shares traded daily over the past several years.

Exela operates in the highly competitive business process automation and information management field. The industry is driven by technological advancements and growing demand for more efficient and cost-effective business solutions.

Exela's competitors include large technology companies such as IBM, Accenture, DXC Technology and smaller, specialized firms. The industry is also subject to regulatory and political pressures, particularly data privacy and security issues.

Exela Technologies Inc has several growth opportunities, including expanding its product offerings and entering new markets. The company has recently launched several new solutions, including Digital Mailroom and Workflow Automation, which have received positive customer feedback.

Exela is also exploring opportunities to expand into new markets, particularly in Asia and Europe. The company has established partnerships with several leading technology firms to support its expansion efforts, including a recent collaboration with Infosys to develop solutions for the insurance industry.

In addition, Exela has made several strategic acquisitions in recent years to enhance its capabilities and expand its customer base. In 2020, the company acquired Asterion, a provider of secure data management solutions and in 2019, it received Conduent's commercial healthcare provider solutions business.

Like any company, Exela Technologies Inc faces several risks and challenges that could impact its performance. One of the biggest challenges for the company is the competitive nature of the industry. Exela competes with both large technology companies and smaller, specialized firms and must continue to innovate to stay ahead.

Another challenge for Exela is the ongoing regulatory and political pressure around data privacy and security issues. The company must ensure that its solutions comply with relevant regulations and is prepared to respond to any regulation changes.

Exela must continue to adapt to changing customer preferences and market conditions. The COVID-19 pandemic, for example, accelerated the shift to remote work and digital solutions, which could impact the demand for some of Exela's services.

XELA Stock Price History

XELA Stock News Headlines

Exela Technologies Inc.
XELA Mar 2024 2.000 put
XELA Mar 2024 3.000 call
Exela Technologies, Inc. (XELA)
XELA Jan 2024 1.000 put
Exela Gains on $15M Contract
Q2 2023 Exela Technologies Inc Earnings Call
See More Headlines
Receive XELA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exela Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Business services, not elsewhere classified
Current Symbol
Year Founded


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$1.06 billion
Book Value
($134.92) per share


Free Float
Market Cap
$14.71 million
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

XELA Stock Analysis - Frequently Asked Questions

How have XELA shares performed in 2024?

Exela Technologies' stock was trading at $3.36 on January 1st, 2024. Since then, XELA stock has decreased by 30.4% and is now trading at $2.34.
View the best growth stocks for 2024 here

When is Exela Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024.
View our XELA earnings forecast

How were Exela Technologies' earnings last quarter?

Exela Technologies, Inc. (NASDAQ:XELA) issued its quarterly earnings results on Wednesday, May, 15th. The company reported $4.27 earnings per share for the quarter. The company earned $258.81 million during the quarter.

When did Exela Technologies' stock split?

Exela Technologies shares reverse split before market open on Monday, May 15th 2023. The 1-200 reverse split was announced on Monday, May 15th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 15th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

What is Ron Cogburn's approval rating as Exela Technologies' CEO?

140 employees have rated Exela Technologies Chief Executive Officer Ron Cogburn on Ron Cogburn has an approval rating of 46% among the company's employees. This puts Ron Cogburn in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Exela Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exela Technologies investors own include Biocept (BIOC), Acasti Pharma (ACST), Avinger (AVGR), Bionano Genomics (BNGO), Heat Biologics (HTBX), T2 Biosystems (TTOO), Onconova Therapeutics (ONTX), Outlook Therapeutics (OTLK), AgEagle Aerial Systems (UAVS).

Who are Exela Technologies' major shareholders?

Exela Technologies' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Murchinson Ltd. (0.00%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Marc A Beilinson, Mark D Fairchild, Par Chadha, Shrikant Sortur and William L Transier.
View institutional ownership trends

How do I buy shares of Exela Technologies?

Shares of XELA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:XELA) was last updated on 6/12/2024 by Staff

From Our Partners